Download PDF
Endoscopy 1999; 31(8): 604-610
DOI: 10.1055/s-1999-13268
Special Topic
Georg Thieme Verlag Stuttgart ·New York

3. Appropriateness of Gastroscopy: Barrett's Esophagus [1]

M. Bochud , J.-J. Gonvers * , J.-P. Vader , R. W. Dubois , B. Burnand , F. Froehlich *
  • * Institut Universitaire de Médecine Sociale et Préventive, Lausanne, Switzerland
  • ** Policlinique Médicale Universitaire, Lausanne, Switzerland
  • *** Protocare Sciences, Santa Monica, USA
Further Information

Publication History

Publication Date:
31 December 1999 (online)

Also available at
    Permissions and Reprints

Introduction

Columnar-lined or Barrett's esophagus is an acquired metaplasia of the distal esophagus that occurs secondary to long-standing gastroesophageal reflux disease (GERD). Patients with Barrett's esophagus have a well-recognized risk of developing an adenocarcinoma of the esophagus and endoscopy combined with biopsy remains the gold standard for the diagnosis of Barrett's.

In November 1998, a multidisciplinary European expert panel convened in Lausanne, Switzerland, to discuss and develop criteria for the appropriate use of gastrointestinal endoscopy, a widely-used procedure, regarded as highly accurate and safe. The RAND appropriateness method was chosen for this purpose, because it allows the development of appropriateness criteria based on published evidence and supplemented by explicit expert opinion. A detailed description of the RAND appropriateness method, including the literature search process [1], and of the whole process, as well as the global results of the panel [2], are published as separate articles in this issue of the Journal. The literature review was based on a systematic search of Medline, Embase and the Cochrane Library conducted up to the end of 1997 and completed with some key articles published in 1998. Updating and revision of the literature review is currently ongoing.

This article presents a literature review on Barrett's esophagus, that was provided to the panelists to study and comment prior to the panel meeting to support their ratings of appropriateness of use of upper gastrointestinal endoscopy. This article furthermore presents an overview of the main panel results related to Barrett's esophagus and a summary of published evidence and panel-based appropriateness criteria.

1 The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE, Lausanne, Switzerland)

References

  • 1 Vader J P, Burnand B, Froehlich F, et al. The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods.  Endoscopy. 1999;  31 572-578
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Vader J P, Froehlich F, Dubois R W, et al. The European Panel on the appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site.  Endoscopy. 1999;  31 687-694
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Fennerty M B, Castell D, Fendrick A M, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.  Arch Intern Med. 1996;  156 477-484
    CrossrefPubMedGoogle Scholar
  • 4 Streitz J M Jr. Barrett's esophagus and esophageal cancer.  Chest Surg Clin N Am. 1994;  4 227-240
    PubMedGoogle Scholar
  • 5 Sharma P, Sampliner R. GERD, DGER, or both in Barrett's esophagus?.  Am J Gastroenterol. 1997;  92 903-904
    PubMedGoogle Scholar
  • 6 Kim S L, Waring J P, Spechler S J, et al. Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group.  Gastroenterology. 1994;  107 945-949
    PubMedGoogle Scholar
  • 7 Tytgat G N. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value?.  Endoscopy. 1995;  27 19-26
    PubMedGoogle Scholar
  • 8 Cameron A J, Zinsmeister A R, Ballard D J, Darney J A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.  Gastroenterology. 1990;  99 918-922
    PubMedGoogle Scholar
  • 9 GOSPE . Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE).  Intern J Cancer. 1991;  48 364-368
    PubMedGoogle Scholar
  • 10 Cameron A J, Lomboy C T. Barrett's esophagus: age, prevalence, and extent of columnar epithelium (see comments).  Gastroenterology. 1992;  103 1241-1245
    CrossrefPubMedGoogle Scholar
  • 11 Lieberman D A, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.  Am J Gastroenterol. 1997;  92 1293-1297
    PubMedGoogle Scholar
  • 12 Winters C J, Spurling T J, Chobanian S J, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.  Gastroenterology. 1987;  92 118-124
    CrossrefPubMedGoogle Scholar
  • 13 Hameetemen W, Tytgat G N, Houthoff H J, van den Tweel J G. Barrett's esophagus: development of dysplasia and adenocarcinoma.  Gastroenterology. 1989;  96 1249-1256
    PubMedGoogle Scholar
  • 14 Robertson C S, Mayberry J F, Nicholson D A, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus.  Brit J Surg. 1988;  75 760-763
    PubMedGoogle Scholar
  • 15 Williamson W A, Ellis F HJ, Gibb S P, et al. Prevalence and incidence of adenocarcinoma.  Arch Intern Med. 1991;  151 2212-2216
    CrossrefPubMedGoogle Scholar
  • 16 Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett's esophagus.  Dig Dis Sci. 1989;  34 1336-1339
    CrossrefPubMedGoogle Scholar
  • 17 Drewitz D J, Sampliner R E, Garewal H S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.  Am J Gastroenterol. 1997;  92 212-215
    PubMedGoogle Scholar
  • 18 Cameron A J, Ott B J, Payne W S, et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.  N Engl J Med. 1985;  313 857-859
    CrossrefPubMedGoogle Scholar
  • 19 Kruse P, Boesby S, Bernstein I T, Andersen I B. Barrett's esophagus and esophageal adenocarcinoma. Endoscopic and histologic surveillance.  Scan J Gastroenterol. 1993;  28 193-196
    PubMedGoogle Scholar
  • 20 Van Der Veen A H. Alimentary tract and pancreas: Adenocarcinoma in Barrett's esophagus: an overrated risk.  Gut. 1989;  30 14-18
    PubMedGoogle Scholar
  • 21 Wright T A, Gray M R, Morris A I, et al. Cost effectiveness of detecting Barrett's cancer.  Gut. 1996;  39 574-579
    CrossrefPubMedGoogle Scholar
  • 22 Provenzale D, Kemp J A, Arora S, Wong J B. A guide for surveillance of patients with Barrett's esophagus.  Am J Gastroenterol. 1994;  89 670-680
    PubMedGoogle Scholar
  • 23 Csendes A, Maluenda F, Braghetto I, et al. Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis.  Gut. 1993;  34 21-27
    CrossrefPubMedGoogle Scholar
  • 24 Spechler S J, Robbins A H, Rubins H B, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk?.  Gastroenterology. 1984;  87 927-933
    PubMedGoogle Scholar
  • 25 Blot W J, Devesa S S, Kneller R W, Fraumeni J FJ. Rising incidence of adenocarcinoma of the esophagus and gastric cardia.  J Am Med Ass. 1991;  265 1287-1289
    CrossrefPubMedGoogle Scholar
  • 26 Sarr M G, Hamilton S R, Marrone G C, Cameron J L. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.  Am J Surg. 1985;  149 187-193
    PubMedGoogle Scholar
  • 27 Fennerty M B. Barrett's esophagus: what do we really know about this disease? [editorial, comment].  Am. J. Gastroenterol.. 1997;  92 (1) 1-3
    PubMedGoogle Scholar
  • 28 Iftikhar S Y, James P D, Steele R J, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.  Gut. 1992;  33 1155-1158
    CrossrefPubMedGoogle Scholar
  • 29 Conio M. Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operative per lo Studio delle Precancerosi Esofagee.  Endoscopy. 1993;  25 642-644
    PubMedGoogle Scholar
  • 30 Reid B J, Blount P L, Rubin C E, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.  Gastroenterology. 1992;  102 1212-1219
    PubMedGoogle Scholar
  • 31 Cameron A J, Carpenter H A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.  Am J Gastroenterol. 1997;  92 586-591
    PubMedGoogle Scholar
  • 32 Levine D S, Haggitt R C, Blount P L, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.  Gastroenterology. 1993;  105 40-50
    CrossrefPubMedGoogle Scholar
  • 33 Reid B J, Haggitt R C, Rubin C E, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.  Human pathology. 1988;  19 166-178
    CrossrefPubMedGoogle Scholar
  • 34 Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.  Gut. 1991;  32 1441-1446
    PubMedGoogle Scholar
  • 35 Beck I T, Champion M C, Lemire S, Thomson A BR. The second Canadian consensus conference on the management of patients with gastroesophageal reflux disease.  Can J Gastroenterol. 1997;  11 7-20B
    PubMedGoogle Scholar
  • 36 Heitmiller R F, Redmond M, Hamilton S R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.  Ann Surg. 1996;  224 66-71
    CrossrefPubMedGoogle Scholar
  • 37 Roth J A. Multimodality treatment of cancer arising from Barrett's epithelium.  World J Surg. 1995;  19 205-209
    CrossrefPubMedGoogle Scholar
  • 38 McDonald M L, Trastek V F, Allen M S, et al. Barrett's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance?.  J Thor Cardiovasc Surg. 1996;  111 1135-1138; discussion 1139 - 1140
    PubMedGoogle Scholar
  • 39 Sharma P, Morales T G, Bhattacharyya A, et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.  Am J Gastroenterol. 1997;  92 2012-2016
    PubMedGoogle Scholar
  • 40 Overholt B F, Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update.  Am J Gastroenterol. 1996;  91 1719-1723
    PubMedGoogle Scholar
  • 41 Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.  Gastrointest Endosc. 1996;  44 700-705
    PubMedGoogle Scholar
  • 42 Sharma P, Sampliner R E, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus (see comments).  Am J Gastroenterol. 1997;  92 582-585
    PubMedGoogle Scholar
  • 43 Ortiz A, Martinez de Haro L F, Parrilla P, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study.  Br J Surg. 1996;  83 274-278
    CrossrefPubMedGoogle Scholar
  • 44 Streitz J M Jr, Andrews C W Jr, Ellis F H Jr. Endoscopic surveillance of Barrett's esophagus. Does it help?.  J Thor Cardiovasc Surg. 1993;  105 383-387
    PubMedGoogle Scholar
  • 45 Peters J H, Clark G W, Chandrasoma P, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.  J Thor Cardiovasc Surg. 1994;  108 813-821; discussion 821 - 822
    PubMedGoogle Scholar
  • 46 Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.  Am J Gastroenterol. 1988;  83 291-294
    PubMedGoogle Scholar
  • 47 De Bosset V, Gonvers J J, Froehlich F, et al. Appropriateness of gastroscopy: Bleeding and dysphagia.  Endoscopy. 1999;  31 615-622
    Article in Thieme ConnectPubMedGoogle Scholar

1 The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE, Lausanne, Switzerland)

Prof. Jean-Jacques Gonvers

Policlinique Médicale Universitaire

Rue César-Roux 19

CH-1005 Lausanne

Switzerland



Fax: + 41-21-3452323

Email: Jean-Jacques.Gonvers@inst.hospvd.ch

      >